Surveillance for artemisinin resistance in West Bengal

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Mono infection with P falciparum detected by microscopy
•parasitaemia of 1000 to 100000 per Âµl asexual forms
•presence of axillary more or equal to 37.5 Â°C or history of fever during the past 48 h
•ability to swallow oral medication
•ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule; and
•Informed consent from the patient or from a parent or guardian in the case of children.

•presence of general danger signs in children aged under 5 years or signs of severe falciparum malaria according to the definitions of WHO
•mixed or mono-infection with another Plasmodium species detected by microscopy
•presence of severe malnutrition
•presence of febrile conditions due to diseases other than malaria (e.g. measles, acute lower respiratory tract infection, severe diarrhoea with dehydration) or other known underlying chronic or severe diseases
•regular medication, which may interfere with antimalarial pharmacokinetics
•history of hypersensitivity reactions or contraindications to any of the medicines being tested or used as alternative treatment and
•a positive pregnancy test or breastfeeding;
•unable to or unwilling to take contraceptives for women of child-bearing age

发起方

ICMR